To assess whether other circulating factors may mediate DKK1 upregulation we treated normal fibroblasts and fibroblasts from patients with scleroderma with serum obtained from patients with SSc (n = 3) prior to and 6 months after RTX treatment. This evidence concerns the gene DKK1 and scleroderma.